Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 11 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

This topical solution is intended for the treatment of fungal toenail infections. The manufacturing will take place at Zydus's facility in Changodar, Ahmedabad. The press release highlights that Tavaborole had annual sales of a specific amount in the United States as of early this year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases